Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Genome-wide Association Study of Pituitary Tumors

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2011 by Huashan Hospital.
Recruitment status was:  Recruiting
Sponsor:
Information provided by (Responsible Party):
Zhaoyun Zhang, Huashan Hospital
ClinicalTrials.gov Identifier:
NCT01442220
First received: September 26, 2011
Last updated: September 27, 2011
Last verified: September 2011
  Purpose
Pituitary adenomas is a very common disease, but the cause and genetics hasn't been identified. The investigators are going to use genome-wide association study to identify genes that may be related to pituitary adenomas.

Condition
Pituitary Adenomas

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Genome-wide Association Study of Pituitary Tumors

Resource links provided by NLM:


Further study details as provided by Huashan Hospital:

Biospecimen Retention:   Samples With DNA
DNA samples

Estimated Enrollment: 12500
Study Start Date: September 2011
Estimated Study Completion Date: July 2014
Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Patients diagnosed with pituitary adenomas and healthy controls will be included.
Criteria

Inclusion Criteria:

  • patients diagnosed with pituitary adenomas

Exclusion Criteria:

  • patients with a family history of endocrine tumors
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01442220

Locations
China, Shanghai
Huashan Hospital
Shanghai, Shanghai, China, 200040
Sponsors and Collaborators
Huashan Hospital
Investigators
Principal Investigator: Yao Zhao, M.D. Huashan Hospital
  More Information

Responsible Party: Zhaoyun Zhang, Doctor, Huashan Hospital
ClinicalTrials.gov Identifier: NCT01442220     History of Changes
Other Study ID Numbers: KY2011-277 
Study First Received: September 26, 2011
Last Updated: September 27, 2011
Health Authority: China: Food and Drug Administration

Additional relevant MeSH terms:
Adenoma
Pituitary Diseases
Pituitary Neoplasms
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms
Hypothalamic Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Endocrine System Diseases
Endocrine Gland Neoplasms
Neoplasms by Site
Hypothalamic Neoplasms
Supratentorial Neoplasms
Brain Neoplasms
Central Nervous System Neoplasms
Nervous System Neoplasms

ClinicalTrials.gov processed this record on December 09, 2016